• Latest Posts

Eterna acquires allogeneic immuno-oncology platform from Exacis 

Vitalli Bio formed to focus on immunological disorders

LIfT BioSciences hails breakthrough data for treating solid tumors

Likang gets trial ok for China’s first personalized cancer vaccine 

Beyond Biotech podcast 35: Rare Disease Day

Positive results for INOVIO recurrent respiratory papillomatosis trial


Genetic study reveals high variation in T-cell receptor genes

Scancell looking to partner after positive COVID vaccine data

Syena created to deliver first-in-class TCR-NK cell therapy

HKUMed uncovers T cell exhaustion factor driving cancer immunotherapy resistance

First leukemia patient dosed with SMART101

Boehringer Ingelheim and 3T Biosciences to develop next-generation cancer immunotherapies